NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
46 hedge funds and large institutions have $184M invested in NexImmune, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$56.4M |
| 2 |
AG
Artal Group
Luxembourg
|
+$26.1M |
| 3 |
SPC
Slate Path Capital
New York
|
+$20.1M |
| 4 |
AO
Allen Operations
New York
|
+$13.8M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$12.6M |
Top Sellers
NEXI Hedge Fund Activity: Q1 2021 in Review
46 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q1 2021, worth a combined $184M.
Buyers outnumbered sellers: 46 funds opened new NEXI positions and 0 closed out — a net gain of 46 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was ArrowMark Colorado Holdings, opening a new position worth an estimated $56.4M.
- 46 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $184M of NexImmune, Inc. Common Stock stock for Q1 2021.
- 46 funds opened new NexImmune, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +46 holders.
- The largest NexImmune, Inc. Common Stock buyer in Q1 2021 was ArrowMark Colorado Holdings, an estimated $56.4M added.
Based on aggregated 13F filings for Q1 2021.